Literature DB >> 19895201

Adenosine A(2A) receptors in early ischemic vascular injury after subarachnoid hemorrhage. Laboratory investigation.

Fatima A Sehba1, Rowena Flores, Artur Muller, Victor Friedrich, Jiang-Fan Chen, Gavin W Britz, H Richard Winn, Joshua B Bederson.   

Abstract

OBJECT: The role of adenosine A(2A) receptors in the early vascular response after subarachnoid hemorrhage (SAH) is unknown. In other forms of cerebral ischemia both activation and inhibition of A(2A) receptors is reported to be beneficial. However, these studies mainly used pharmacological receptor modulation, and most of the agents available exhibit low specificity. The authors used adenosine A(2A) receptor knockout mice to study the role of A(2A) receptors in the early vascular response to SAH.
METHODS: Subarachnoid hemorrhage was induced in wild-type mice (C57BL/6) and A(2A) receptor knockout mice by endovascular puncture. Cerebral blood flow, intracranial pressure, and blood pressure were recorded, and cerebral perfusion pressure was deduced. Animals were sacrificed at 1, 3, or 6 hours after SAH or sham surgery. Coronal brain sections were immunostained for Type IV collagen, the major protein of the basal lamina. The internal diameter of major cerebral arteries and the area fraction of Type IV collagen-positive microvessels (< 100 μm) were determined.
RESULTS: The initial increase in intracranial pressure and decrease in cerebral perfusion pressure at SAH induction was similar in both types of mice, but cerebral blood flow decline was significantly smaller in A(2A) receptor knockout mice as compared with wild-type cohorts. The internal diameter of major cerebral vessels decreased progressively after SAH. The extent of diameter reduction was significantly less in A(2A) receptor knockout mice than in wild-type mice. Type IV collagen immunostaining decreased progressively after SAH. This decrease was significantly less in A(2A) receptor knockout mice than in wild-type mice.
CONCLUSIONS: These results demonstrate that global inactivation of A(2A) receptors decreases the intensity of the early vascular response to SAH. Early inhibition of A(2A) receptors after SAH might reduce cerebral injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19895201      PMCID: PMC2889623          DOI: 10.3171/2009.9.JNS09802

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  38 in total

Review 1.  Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.

Authors:  Sergi Ferre; Francisco Ciruela; Janusz Borycz; Marcello Solinas; Davide Quarta; Katerina Antoniou; Cesar Quiroz; Zuzana Justinova; Carme Lluis; Rafael Franco; Steven R Goldberg
Journal:  Front Biosci       Date:  2008-01-01

Review 2.  Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.

Authors:  Kjell Fuxe; Sergi Ferré; Susanna Genedani; Rafael Franco; Luigi F Agnati
Journal:  Physiol Behav       Date:  2007-05-21

3.  Time-dependent alterations in functional and pharmacological arteriolar reactivity after subarachnoid hemorrhage.

Authors:  Gavin W Britz; Joseph R Meno; Ik-Seong Park; Taylor J Abel; Abhineet Chowdhary; Thien-Son K Nguyen; H Richard Winn; Al C Ngai
Journal:  Stroke       Date:  2007-02-22       Impact factor: 7.914

Review 4.  Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.

Authors:  Jiang-Fan Chen; Patricia K Sonsalla; Felicita Pedata; Alessia Melani; Maria Rosaria Domenici; Patrizia Popoli; Jonathan Geiger; Luísa V Lopes; Alexandre de Mendonça
Journal:  Prog Neurobiol       Date:  2007-09-29       Impact factor: 11.685

5.  Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway.

Authors:  Peng Zhao; Xin-gang Li; Meixiang Yang; Qianqian Shao; Donghai Wang; Shuxun Liu; Haibo Song; Bingfeng Song; Yan Zhang; Xun Qu
Journal:  Mol Immunol       Date:  2008-01-22       Impact factor: 4.407

6.  Cerebral blood flow response in adenosine 2a receptor knockout mice during transient hypoxic hypoxia.

Authors:  Greg Miekisiak; Tobias Kulik; Yoshikazu Kusano; David Kung; Jiang-Fan Chen; H Richard Winn
Journal:  J Cereb Blood Flow Metab       Date:  2008-06-11       Impact factor: 6.200

Review 7.  Adenosine as a neuromodulator in neurological diseases.

Authors:  Detlev Boison
Journal:  Curr Opin Pharmacol       Date:  2007-10-17       Impact factor: 5.547

8.  Attenuation of experimental subarachnoid hemorrhage--induced cerebral vasospasm by the adenosine A2A receptor agonist CGS 21680.

Authors:  Chih-Lung Lin; Huei-Chuan Shih; Ann-Shung Lieu; Kung-Shing Lee; Aaron S Dumont; Neal F Kassell; Shen-Long Howng; Aij-Lie Kwan
Journal:  J Neurosurg       Date:  2007-03       Impact factor: 5.115

9.  Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor.

Authors:  Fatima A Sehba; Victor Friedrich; Girma Makonnen; Joshua B Bederson
Journal:  J Neurosurg       Date:  2007-02       Impact factor: 5.115

10.  An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models.

Authors:  Christopher C Moore; Edward N Martin; Grace H Lee; Tom Obrig; Joel Linden; W Michael Scheld
Journal:  BMC Infect Dis       Date:  2008-10-20       Impact factor: 3.090

View more
  13 in total

1.  A Systematic and Meta-Analysis of Mortality in Experimental Mouse Models Analyzing Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

Authors:  Marcel A Kamp; Jasper H van Lieshout; Maxine Dibué-Adjei; Jasmin K Weber; Toni Schneider; Tanja Restin; Igor Fischer; Hans-Jakob Steiger
Journal:  Transl Stroke Res       Date:  2017-01-30       Impact factor: 6.829

Review 2.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

Review 3.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

Review 4.  Early brain injury, an evolving frontier in subarachnoid hemorrhage research.

Authors:  Mutsumi Fujii; Junhao Yan; William B Rolland; Yoshiteru Soejima; Basak Caner; John H Zhang
Journal:  Transl Stroke Res       Date:  2013-08       Impact factor: 6.829

Review 5.  Subarachnoid hemorrhage: a review of experimental studies on the microcirculation and the neurovascular unit.

Authors:  Michael K Tso; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2014-02-11       Impact factor: 6.829

Review 6.  Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury.

Authors:  Fatima A Sehba; Ryszard M Pluta; John H Zhang
Journal:  Mol Neurobiol       Date:  2010-12-15       Impact factor: 5.590

7.  Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage.

Authors:  Victor Friedrich; Rowena Flores; Artur Muller; Weina Bi; Ellinor Ib Peerschke; Fatima A Sehba
Journal:  J Neuroinflammation       Date:  2011-08-19       Impact factor: 8.322

8.  Gender influences the initial impact of subarachnoid hemorrhage: an experimental investigation.

Authors:  Victor Friedrich; Joshua B Bederson; Fatima A Sehba
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  Methazolamide improves neurological behavior by inhibition of neuron apoptosis in subarachnoid hemorrhage mice.

Authors:  Mingchang Li; Wei Wang; Haojian Mai; Xinmu Zhang; Jian Wang; Yufeng Gao; Yuefei Wang; Gang Deng; Ling Gao; Shuanhu Zhou; Qianxue Chen; Xin Wang
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

Review 10.  To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.

Authors:  Giulia Cossu; Mahmoud Messerer; Mauro Oddo; Roy Thomas Daniel
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.